Scientific and technical support work related to hazard assessment and identification, including regulatory support of work on CLP, Dossier and Substance Evaluation, POPs, DWD and future tasks under certain water protection directives
Expired
The competition has expired without a winner being announced.
- Deadline
- Apr 30, 2024Expired
- Award
- Pris 35%
Brief
ECHA secretariat needs flexible support to address emerging regulatory challenges related to the (eco)toxicological assessments of substances. Within the changing regulatory landscape, new hazard properties need to be addressed (e.g. neurotoxicity, immunotoxicity, endocrine disruption) which require specific scientific and technical expertise in order to assess and identify these specific adverse properties. New and emerging methodologies (preferably without using animal testing) need to be assessed, developed or finetuned, allowing decision making within the framework of REACH and CLP. These new framework contracts will help the Agency to address these emerging scientific challenges, while at the same time provide support to ongoing or new regulatory processes that ECHA is executing.
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Vennligst se anskaffelsesdokumentene.
Source
No source found in the documents. Check the weight against the tender documents.
Description
Vennligst se anskaffelsesdokumentene.
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at European Chemicals Agency
From the notice
ECHA secretariat needs flexible support to address emerging regulatory challenges related to the (eco)toxicological assessments of substances. Within the changing regulatory landscape, new hazard properties need to be addressed (e.g. neurotoxicity, immunotoxicity, endocrine disruption) which require specific scientific and technical expertise in order to assess and identify these specific adverse properties. New and emerging methodologies (preferably without using animal testing) need to be assessed, developed or finetuned, allowing decision making within the framework of REACH and CLP. These new framework contracts will help the Agency to address these emerging scientific challenges, while at the same time provide support to ongoing or new regulatory processes that ECHA is executing.
Contact
procurement@echa.europa.eu- Competition · Framework agreementType
- 73000000Main codeResearch and development services and related consultancy services